Racial and Ethnic Diversity in Studies Funded Under the Best Pharmaceuticals for Children Act.

ABSTRACT:

Background and objectives

The Best Pharmaceuticals for Children Act (BPCA) incentivizes the study of on-patent medicines in children and mandates that the National Institutes of Health sponsor research on off-patent drugs important to pediatric therapeutics. Failing to enroll cohorts that reflect the pediatric population at large restricts the generalizability of such studies. In this investigation, we evaluate racial and ethnic minority representation among participants enrolled in BPCA-sponsored studies.

Methods

Data were obtained for all participants enrolled in 33 federally funded studies of drugs and devices conducted from 2008 through June 2020. Observed racial and ethnic distributions were compared with expected distributions by sampling Census data at the same geogra

SUBMITTER: Abdel-Rahman SM 

PROVIDER: S-EPMC9713833 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature